Figure 1 (Vizamyl 01)
Vizamyl Solution
Product Images NDC 17156-067
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vizamyl (NDC 17156-067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ge Healthcare Inc. (medi-physics, Inc. Dba Ge Healthcare), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Vizamyl 02)
Figure 3 (Vizamyl 03)
This is a very short text that does not give enough information to generate a useful description. It appears to be referencing something called "pc" and two types of scans, positive and negative, but without further context or information it is not possible to provide a meaningful interpretation.*
Chemical Structure (Vizamyl 04)
Principal Display Panel (Shield Label)
NDC 17156-067-30 is a multiple dose vial of Vizamyl (Flutemetamol F 18 Injection). It contains 150 MBq (4.05 mCi) of flutemetamol, 7% ethanol, 0.9% sodium chloride, and 0.5% polysorbate 80 in 0.014 M phosphate buffer. The injection is sterile, non-pyrogenic, and intended for intravenous use only. The solution can be stored between 2°C to 30°C (35.6°F to 86°F). The product is manufactured by Cardinal Health 414, LLC for GE Healthcare, Medi-Physics Inc. in the U.S.A. The batch number, date, and vial number are also mentioned. The expiry date is not given.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
